CD8A and cancer: To further understand the impact of the cancer vaccine vector VSV-GP on CD8+ T cell immunity, a comprehensive investigation was conducted in this study to decipher the factors influencing target antigen- as well as anti-viral-specific CD8+ T cells in terms of magnitude and quality.